SELLAS Life Sciences Group, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-26.0M | $-26.0M | — | $1.0M |
| FY2022 | $-23.8M | $-23.8M | — | $1.7M |
| FY2023 | $-31.4M | $-31.4M | — | $2.1M |
| FY2024 | $-35.4M | $-35.4M | — | $1.6M |
| FY2025 | $-28.4M | $-28.4M | — | $2.0M |